{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:15:01Z","timestamp":1783703701305,"version":"3.55.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1093\/chromsci\/bmx068","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T11:16:48Z","timestamp":1501586208000},"page":"99-107","source":"Crossref","is-referenced-by-count":12,"title":["Stability-Indicating Liquid Chromatographic Methods with Photodiode Array Detection and Light Scattering Detection for Simultaneous Determination of Candesartan and Hydrochlorothiazide"],"prefix":"10.1093","volume":"56","author":[{"given":"Marta","family":"de Diego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Mennickent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00eda","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"key\n\t\t\t\t20180119095137_bmx068C1","first-page":"2058","volume-title":"AHFS Drug Information","year":"2014"},{"key":"key\n\t\t\t\t20180119095137_bmx068C2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/157341211797458005","article-title":"A validated stability-indicating LC method for simultaneous determination of enalapril and hydrochlorothiazide in pharmaceutical samples","volume":"7","year":"2011","journal-title":"Current Pharmaceutical Analysis"},{"key":"key\n\t\t\t\t20180119095137_bmx068C3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2004.07.050","article-title":"Stability study of losartan\/hydrochlorothiazide tablets","volume":"291","year":"2005","journal-title":"International Journal of Pharmaceutics"},{"key":"key\n\t\t\t\t20180119095137_bmx068C4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0731-7085(02)00385-0","article-title":"Development and validation of a stability-indicating HPLC method for the simultaneous determination of losartan potassium, hydrochlorothiazide, and their degradation products","volume":"30","year":"2002","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key\n\t\t\t\t20180119095137_bmx068C5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jpba.2008.11.001","article-title":"Stability of selected chlorinated thiazide diuretics","volume":"49","year":"2009","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key\n\t\t\t\t20180119095137_bmx068C6","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/jps.1130","article-title":"Purification and identification of an impurity in bulk hydrochlorothiazide","volume":"90","year":"2001","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"key\n\t\t\t\t20180119095137_bmx068C7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1365\/s10337-007-0364-x","article-title":"A stability-indicating LC method for candesartan cilexetil","volume":"66","year":"2007","journal-title":"Chromatographia"},{"key":"key\n\t\t\t\t20180119095137_bmx068C8","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1365\/s10337-009-1066-3","article-title":"Identication, isolation, and characterization of five potential degradation impurities in candesartan cilexetil tablets","volume":"69","year":"2009","journal-title":"Chromatographia"},{"key":"key\n\t\t\t\t20180119095137_bmx068C9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jpba.2009.05.006","article-title":"LC and LC-MS\/TOF studies on stress degradation behaviour of candesartan cilexetil","volume":"52","year":"2010","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key\n\t\t\t\t20180119095137_bmx068C10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.5740\/jaoacint.11-106","article-title":"Stability-indicating methods for the determination of candesartan cilexetil in bulk drug and pharmaceutical formulations","volume":"96","year":"2013","journal-title":"Journal of AOAC International"},{"key":"key\n\t\t\t\t20180119095137_bmx068C11","first-page":"142","volume-title":"Pharmaceutical Stress Testing, Predicting Drug Degradation","year":"2005"},{"key":"key\n\t\t\t\t20180119095137_bmx068C12","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.talanta.2011.04.012","article-title":"Comparison of two aerosol-based detectors for the analysis of gabapentin in pharmaceutical formulations by hydrophilic interaction cromatography","volume":"85","year":"2011","journal-title":"Talanta"},{"key":"key\n\t\t\t\t20180119095137_bmx068C13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jpba.2009.10.019","article-title":"Comparison of ultraviolet detection, evaporative light scattering detection and charged aerosol detection methods for liquid-chromatographic determination of anti-diabetic drugs","volume":"51","year":"2010","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key\n\t\t\t\t20180119095137_bmx068C14","first-page":"277","volume-title":"The Pharmaceutical Codex","year":"1994","edition":"12th ed"},{"key":"key\n\t\t\t\t20180119095137_bmx068C15"},{"issue":"5","key":"key\n\t\t\t\t20180119095137_bmx068C16","first-page":"720","article-title":"Stability indicating RP-HPLC method for the simultaneous determination of candesartan cilexetil and hydrochlorothiazide in bulk and dosage forms","volume":"1","year":"2013","journal-title":"Indian Journal of Research in Pharmacy and Biotechnology"},{"key":"key\n\t\t\t\t20180119095137_bmx068C17","first-page":"166","article-title":"Development and validation of a RP-HPLC method for estimation of hydrochlorothiazide and candesartan cilexetil in pharmaceutical dosage form","volume":"3","year":"2013","journal-title":"International Journal of Pharmacy"},{"key":"key\n\t\t\t\t20180119095137_bmx068C18","first-page":"119","article-title":"Simple and sensitive LC-UV method for simultaneous analysis of hydrochlorothiazide and candesartan cilexetil in pharmaceutical formulations","volume":"19","year":"2007","journal-title":"Acta Chromatographica"},{"key":"key\n\t\t\t\t20180119095137_bmx068C19","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1081\/JLC-120023802","article-title":"Simultaneous analysis of candesartan cilexetil and hydrochlorothiazide in human plasma and dosage forms using HPLC with photodiode array detector","volume":"26","year":"2003","journal-title":"Journal of Liquid Chromatography and Related Technologies"},{"key":"key\n\t\t\t\t20180119095137_bmx068C20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2478\/s11532-013-0396-z","article-title":"A validated stability-indicating LC method for simultaneous determination of quinapril and hydrochlorothiazide in pharmaceutical samples","volume":"12","year":"2014","journal-title":"Central European Journal of Chemuistry"},{"key":"key\n\t\t\t\t20180119095137_bmx068C21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0731-7085(00)00474-X","article-title":"A stability-indicating LC method for the simultaneous determination of ramipril and hydrochlorothiazide in dosage forms","volume":"24","year":"2001","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key\n\t\t\t\t20180119095137_bmx068C22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/chrsci\/49.2.129","article-title":"Validated chromatographic methods for determination of hydrochlorothiazide and spironolactone in pharmaceutical formulation in presence of impurities and degradants","volume":"49","year":"2011","journal-title":"Journal of Chromatographic Science"},{"key":"key\n\t\t\t\t20180119095137_bmx068C23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/chromsci\/48.7.595","article-title":"Stability indicating LC method for simultaneous determination of irbesartan and hydrochlorothiazide in pharmaceutical preparations","volume":"48","year":"2010","journal-title":"Journal of Chromatographic Science"},{"key":"key\n\t\t\t\t20180119095137_bmx068C24","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.5740\/jaoacint.13-383","article-title":"A stability-indicating HPLC method for the quantification of aliskiren and hydrochlorothiazide in a pharmaceutical formulation","volume":"97","year":"2014","journal-title":"Journal of AOAC International"},{"key":"key\n\t\t\t\t20180119095137_bmx068C25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1365\/s10337-009-1221-x","article-title":"Simultaneous determination of losartan potassium atenolol and hydrochlorothiazide in pharmaceutical preparations by stability-indicating UPLC","volume":"70","year":"2009","journal-title":"Chromatographia"},{"key":"key\n\t\t\t\t20180119095137_bmx068C26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpba.2015.01.059","article-title":"A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form","volume":"109","year":"2015","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"key\n\t\t\t\t20180119095137_bmx068C27"},{"key":"key\n\t\t\t\t20180119095137_bmx068C28"},{"key":"key\n\t\t\t\t20180119095137_bmx068C29"},{"key":"key\n\t\t\t\t20180119095137_bmx068C30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.trac.2013.05.008","article-title":"Practical and regulatory considerations for stability-indicating methods for the assay of bulk and drug formulations","volume":"49","year":"2013","journal-title":"Trends in Analytical Chemistry"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/chromsci\/article-pdf\/56\/2\/99\/23572146\/bmx068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T14:51:51Z","timestamp":1516373511000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/chromsci\/article\/56\/2\/99\/4719610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,12,11]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmx068","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,12,11]]}}}